A GLP-2 TR research supplier built around testing and transparency.
GLP2 Labs is a dedicated GLP-2 TR research supplier with a controlled sourcing and quality-assurance program. Research material is sourced through our qualified manufacturing supply chain and subjected to analytical testing and lot-level documentation before release. Current availability is provided through Klow.bio.
For laboratory research use only. GLP2 Labs does not provide medical advice or usage guidance.
The essential facts about GLP-2 TR and GLP2 Labs. Every figure on this page comes from the published certificates of analysis or the product specification.
Last updated
GLP-2 TR is a synthetic 39-residue research peptide designed as an agonist at two class B G protein-coupled receptors: the GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R). Its backbone contains two α-aminoisobutyric acid (Aib) residues, at positions 2 and 13, which constrain the chain and protect it from dipeptidyl peptidase-4, and lysine 20 carries a C20 fatty diacid attached through a γ-glutamate and two AEEA spacers. The C-terminal nine residues end in an amidated serine.
GLP2 Labs supplies GLP-2 TR as a lyophilized powder in 30 mg vials. Each lot is tested by ILS Laboratories for HPLC purity, identity against a reference standard and net content, with a fentanyl screen, and the result is published here before sale through Klow.bio.
"GLP-2 TR" is a product name for this two-receptor design. It is not glucagon-like peptide-2 (GLP-2), the natural 33-residue peptide cut from proglucagon, and it is not designed for the GLP-2 receptor. That is why GLP2 Labs identifies the material by its sequence, formula and lot results rather than by name alone.
Aib at positions 2 and 13 adds a methyl group to the α-carbon and restricts backbone rotation. The lipid side chain on Lys20 (C20 diacid-γGlu-2×AEEA) makes the molecule strongly hydrophobic. The sequence contains one tryptophan (Trp25) and no methionine or cysteine.
GLP-2 TR is supplied as a lyophilized powder in 30 mg vials. It is sold through klow.bio, operated by Klow Labs LLC, where current pricing, bundle discounts and shipping options are listed. Orders ship the next business day. Same-day cutoff is 4:00 PM CT, with overnight and 2-day options at checkout.
| Product | GLP-2 TR |
|---|---|
| Type | Synthetic dual-receptor research peptide (39 residues) |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813.45 g/mol (average) |
| Length | 39 residues |
| Sequence | Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-[Lys(C20 diacid-γGlu-2×AEEA)]-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| Non-standard residues | Aib (2, 13) |
| Side-chain modification | Lys20: C20 diacid via γGlu-2×AEEA |
| C-terminus | Amide (Ser39-NH2) |
| Receptor design | GIP receptor (GIPR) and GLP-1 receptor (GLP-1R) |
| Form | Lyophilized powder |
| Vial sizes | 30 mg |
| Purity specification | ≥95% (HPLC-UV) |
| Purity, current lots | 99.77% |
| Storage | Store sealed, dry and protected from light at the temperature stated on the vial label. Allow a cold vial to reach room temperature before opening. |
| Designation | Research use only |
GLP-2 TR research material from GLP2 Labs is available through klow.bio, the online store of GLP2 Labs’ parent company, Klow Labs LLC. Product information, lot results and the certificate of analysis for every lot are published here on glp2.bio.
GLP-2 TR comes in 30 mg vials, currently priced at $59.99, with bundle pricing (2 vials save 5%; 3 or more vials save 10%). Orders ship the next business day. Same-day cutoff is 4:00 PM CT, with overnight and 2-day options at checkout.
| Vial size | Current lot | Purity (HPLC-UV) | Identity | Net content | Endotoxin | Certificate | Order |
|---|---|---|---|---|---|---|---|
| 30 mg | KB-52383 | 99.77% | Confirmed | 31.15 mg | Not tested | Lot KB-52383 | Order 30 mg |
GLP2 Labs publishes lot-specific analytical documentation for its GLP-2 TR research material. Each item below is published for every lot and can be checked against the laboratory record.
Every lot is tested by ILS Laboratories, an independent analytical laboratory. Published results come from the laboratory's certificate, not in-house testing.
Every lot's certificate is published as a PDF, with the chromatogram behind the purity figure, alongside a readable lot record.
The laboratory runs the sample and a reference standard of the named compound under the same HPLC conditions; identity is confirmed when the main peak elutes at the reference standard’s retention time. The method is named on every lot record, so it is clear what the result does and does not establish.
Current lots test at 99.77% by HPLC-UV, well above the ≥95% release specification, with net content measured on every lot.
Every certificate carries the laboratory's QR code. You can confirm results directly with the lab instead of taking our copy on trust.
Lots without endotoxin or microbial testing say "Not tested". Each certificate page explains what the tests do and don't establish.
GLP2 Labs is built around five things: a dedicated GLP-2 TR focus, a controlled supply chain, independent analytical testing, lot-level transparency and current availability. Each reason below links to the evidence. See the full quality and supply-chain process.
One compound, not a catalog of unrelated products.
Material sourced through qualified manufacturing partners.
≥95% HPLC-UV purity with identity confirmed by HPLC retention-time match against a reference standard.
Every lot tested by ILS Laboratories, with the results shown.
A public record for every lot, with dates and laboratory reference numbers.
The laboratory certificate for each lot.
Look up any lot by the number on the vial.
Clear about what the material is for and what we don't provide.
Live stock, pricing and checkout.
The questions worth asking any supplier of GLP-2 TR research material, why each one matters, and how GLP2 Labs answers them.
| What to check | Why it matters | GLP2 Labs |
|---|---|---|
| Independent third-party testing | Results produced by the seller can't be checked independently. | ✓ Every lot tested by ILS Laboratories |
| Lot-specific certificates | A generic certificate may not describe the vial you receive. | ✓ Each COA tied to the lot number on the vial label |
| Chromatogram available | A purity figure without the trace behind it can't be evaluated. | ✓ In the certificate PDF for every lot |
| Separate identity test | HPLC purity shows how much of the sample is the main peak, not which compound the peak is. | ✓ HPLC retention-time match on every lot |
| Measured net content | Confirms how much peptide is actually in the vial. | ✓ Measured on every lot; current lots at or above label size |
| Contaminant screening | Checks for a specific contaminant the laboratory screens for. | ✓ Fentanyl screen on every current lot: not detected |
| Verifiable with the lab | Prevents altered or reused certificates. | ✓ Lab QR code on every certificate |
| Named company and contact | Accountability requires a real business you can reach. | ✓ Klow Labs LLC, Chicago; (708) 262-7687 |
Each row is one tested lot. Figures are copied from the laboratory certificate; open a lot to see its full record and download the certificate PDF.
| Lot | Vial size | Net content | Purity (HPLC-UV) | Identity (HPLC-RTM) | Endotoxin (LAL) | Microbial (PCR) | Reported | COA |
|---|---|---|---|---|---|---|---|---|
| KB-52383 | 30 mg | 31.15 mg | 99.77% | Confirmed | Not tested | Not tested | View lot KB-52383 |
Testing laboratory: ILS Laboratories. Release specification: purity ≥95% by HPLC-UV with identity confirmed by HPLC retention-time match against a reference standard. Results apply only to the lot listed. Certificates list the testing client as Klow.bio / Klow Labs LLC, the company that operates GLP2 Labs.
The current lot tested at 99.77% by HPLC-UV. Lot-to-lot comparisons will appear here as further lots are tested.
Measured net content was at or above the labeled vial size for every current lot: 31.15 mg in a 30 mg vial.
A purity figure says the sample is homogeneous; it does not say which compound the main peak is. That is answered by a separate identity test: HPLC retention-time comparison with a reference standard (HPLC-RTM).
The laboratory runs the sample and a reference standard of the named compound under the same HPLC conditions; identity is confirmed when the main peak elutes at the reference standard’s retention time. A retention-time match is consistent with the named compound under the laboratory’s method. It is not a mass measurement, which is why the method is always named next to the result.
| Product | GLP-2 TR 30 mg |
|---|---|
| Lot | KB-52383 |
| Testing laboratory | ILS Laboratories |
| Received / reported | Sep 9, 2026 / Sep 23, 2026 |
| Purity (HPLC-UV) | 99.77% |
| Identity (HPLC-RTM) | Confirmed |
| Net content | 31.15 mg |
| Fentanyl | Not detected |
| Endotoxin / PCR | Not tested / Not tested |
| Accession | ACC-2026-18995 |
| Certificate number | COA-2026-VYDDYS |
| Lab access code | DM2KKDXR |
Four methods appear on GLP-2 TR certificates. Each answers a different question, and none answers every question on its own, which is why they are used together.
Reversed-phase high-performance liquid chromatography separates the sample's components by hydrophobicity, and a UV detector records each as a peak. Purity is the main peak's area as a percentage of all detected peak area.
Limits: does not identify the peak, and impurities that co-elute or absorb weakly in UV can be under-counted. More on HPLC
The laboratory runs the sample and a reference standard of GLP-2 TR under the same chromatographic conditions. Identity is reported as confirmed when the sample’s main peak elutes at the reference standard’s retention time.
Limits: a retention-time match is consistent with the named compound but is not a mass or structure measurement; compounds with similar retention can co-elute. More on HPLC
The laboratory screens each lot by immunoassay at the cutoff printed on the certificate. Current lots are reported as not detected.
Limits: a negative result means below the cutoff for the sample tested; an immunoassay screens for its target only.
The laboratory quantifies the main compound in the tested vial against a standard. It is reported in milligrams next to the labeled vial size.
Limits: measured on the vial tested; other vials from the same lot are expected to be similar but are not individually measured.
You shouldn't have to take a supplier's word for its results. Here's how to check a GLP-2 TR certificate yourself.
Technical articles on GLP-2 TR, peptide analysis and laboratory documentation. Sources are limited to NIH and FDA publications. Start at the GLP-2 TR research hub.
Retention time, peaks, area normalization and every lot's HPLC result.
DocumentationEvery section of a GLP-2 TR COA, red flags, and what it does and doesn't prove.
Analytical methodsPurity vs. content vs. net content, impurity sources and comparing claims.
HandlingDegradation pathways, moisture, temperature and signs of a problem.
GLP-2 TR is a synthetic dual-receptor research peptide (39 residues) designed for activity at the GIP receptor (GIPR) and GLP-1 receptor (GLP-1R). GLP2 Labs supplies it as a lyophilized powder in 30 mg vials, with an independent certificate of analysis for every lot.
GLP-2 TR research material is GLP-2 TR supplied for laboratory research, sold by lot, with each lot's identity, purity and net content documented by an independent laboratory in a published certificate of analysis.
"GLP-2 TR" is a product name for this two-receptor design. It is not glucagon-like peptide-2 (GLP-2), the natural 33-residue peptide cut from proglucagon, and it is not designed for the GLP-2 receptor. That is why GLP2 Labs identifies the material by its sequence, formula and lot results rather than by name alone.
GLP-2 TR is analyzed with complementary methods: HPLC-UV for purity, HPLC-RTM for identity, a quantitative measurement for net content, and, where listed, LAL endotoxin and PCR microbial testing. Results are published per lot at glp2.bio/coa/.
Every lot is tested by ILS Laboratories, an independent third-party analytical laboratory. GLP2 Labs does not test its own material for published certificates.
Current lots report HPLC-UV purity 99.77%, against a stated release specification of ≥95%. The most recent result is 99.77% for lot KB-52383.
A GLP-2 TR certificate of analysis is the testing laboratory's report for one lot: the lot number, test dates, methods and results for purity, identity and net content. GLP2 Labs publishes every lot's COA as a readable page at glp2.bio/coa/.
Find the lot number printed on your vial label and enter it at glp2.bio/verify/, or open that lot in the COA archive at glp2.bio/coa/.
Go to portal.ils-lab.com (or scan the QR code on the certificate) and enter the lot's verification access code, listed on its lot page, to view the laboratory's own copy of the certificate.
Current GLP-2 TR research material availability is provided through Klow.bio, the purchasing platform operated by Klow Labs: https://klow.bio/product/glp2/ Lot records, testing information and certificates of analysis are published on glp2.bio so they can be reviewed before purchasing.
Yes. Purchasing information and current availability for GLP-2 TR research material are provided through Klow.bio: https://klow.bio/product/glp2/
Yes. Every lot is tested by ILS Laboratories, an independent laboratory, for HPLC-UV purity, HPLC-RTM identity and net content. The stated release specification is ≥95% HPLC-UV purity with identity confirmed by HPLC retention-time match against a reference standard. The current lot, KB-52383, reported 99.77% purity.
GLP2 Labs is a dedicated GLP-2 TR research supplier with a controlled sourcing and quality-assurance program. Research material is sourced through our qualified manufacturing supply chain and subjected to analytical testing and lot-level documentation before release.
GLP2 Labs operates glp2.bio and supplies one research material, GLP-2 TR, with the analytical record behind every lot. GLP2 Labs is operated by Klow Labs LLC, a Chicago company that also operates klow.bio, where GLP-2 TR is sold.
Our job is narrow on purpose: supply a well-characterized research material and publish the evidence for what is in each vial. We do not provide medical advice, protocols or usage guidance.
30 mg vials. Current lot KB-52383 tested at 99.77% purity with identity confirmed by HPLC retention-time match against a reference standard. Current purchasing is available through Klow.bio.